Addex Therapeutics annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
Addex Therapeutics Operating Margin Growth & History (ADXN)
Addex Therapeutics's operating margin was −9,390.76% for fiscal 2025.
View full Addex Therapeutics company overviewAddex Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −9,390.76% | −8718.82 pp |
| 2024 | 2024-12-31 | −671.94% | −533.24 pp |
| 2023 | 2023-12-31 | −138.70% | +590.80 pp |
| 2022 | 2022-12-31 | −729.49% | −237.76 pp |
| 2021 | 2021-12-31 | −491.74% | −176.12 pp |
| 2020 | 2020-12-31 | −315.62% | +199.76 pp |
| 2019 | 2019-12-31 | −515.38% | −494.13 pp |
| 2018 | 2018-12-31 | −21.25% | +625.89 pp |
| 2017 | 2017-12-31 | −647.15% | — |
Addex Therapeutics quarterly operating margin
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −314,218.95% | — |
| Q3 2025 | 2025-09-30 | −2,342.13% | — |
| Q2 2025 | 2025-06-30 | −2,014.84% | −1234.71 pp |
| Q2 2024 | 2024-06-30 | −780.13% | −377.15 pp |
| Q2 2023 | 2023-06-30 | −402.99% | +3400.97 pp |
| Q2 2022 | 2022-06-30 | −3,803.96% | −3383.52 pp |
| Q2 2021 | 2021-06-30 | −420.44% | — |
Addex Therapeutics operating margin trends
Over the last five fiscal years, Addex Therapeutics's operating margin decreased from −315.62% to −9,390.76%, a change of −9075.14 percentage points. The latest reported quarter, Q4 2025, shows −314,218.95%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Addex Therapeutics source filings ↗Community posts
Addex reports limited cash as half-year loss reaches CHF3.46 million
Addex Therapeutics ($ADXN) reported a first-half net loss of CHF3.46 million, compared with CHF3.31 million a year earlier. Its operating loss narrowed to CHF1.13 million, but the share of losses from associates increased to CHF2.33 million ...
